Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yikangning
- Development stage
- Phase 3
- Lead developer
- Hainan Sihuan Cardiocerebral Vascular Drugs Research Institute
- Administration
- Oral
01
Overview
Yikangning is a Traditional Chinese Medicine (TCM) herbal formulation, often encountered as "Yikang Capsules" or "Yikang Decoction". As a TCM, it comprises multiple natural ingredients, such as ginseng, astragalus, salvia miltiorrhiza, and ganoderma lucidum, among others. Its therapeutic approach is holistic, aiming to restore balance within the body according to TCM principles like Qi, yin, and yang. Research, particularly for conditions like Polycystic Ovary Syndrome (PCOS), indicates a multi-target mechanism involving numerous active components that modulate various biological processes and signaling pathways.
- Brand names
- Yikang Capsules
- Other names
- YKD
Beyond the preview
Go deeper on Yikangning.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yikangning.